Page last updated: 2024-12-07

2-(4'-isothiocyanatobenzyl)imidazoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(4'-isothiocyanatobenzyl)imidazoline: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID125413
CHEMBL ID59034
MeSH IDM0193604

Synonyms (9)

Synonym
2-ibi
CHEMBL59034
2-[(4-isothiocyanatophenyl)methyl]-4,5-dihydro-1h-imidazole
130262-94-1
2-(4'-isothiocyanatobenzyl)imidazoline
4,5-dihydro-2-((4-isothiocyanatophenyl)methyl)-1h-imidazole
1h-imidazole, 4,5-dihydro-2-((4-isothiocyanatophenyl)methyl)-
DTXSID80156433
2-(4/'-isothiocyanatobenzyl)imidazoline
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID196939Concentration that produces 50% of the maximal response to compound in rat thoracic aorta strips in the presence of nifedipine1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID16760Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID196935Concentration that produces 50% of the maximal response to compound in rat thoracic aorta strips in the presence of PBZ and IDA at 0.1 uM1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID196937Concentration that produces 50% of the maximal response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID16755Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID196943Concentration that produces 50% of the maximal response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID16756Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID16757Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID196932Concentration that produces 50% of the maximal response to compound in rat thoracic aorta strips1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID196940Concentration that produces 50% of the maximal response to compound in rat thoracic aorta strips in the presence of verapamil1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID16758Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID196936Concentration that produces 50% of the maximal response to compound in rat thoracic aorta strips in the presence of PBZ and IDA at 1 uM1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID19939Percent of maximal contractile response to compound in rat thoracic aorta strips1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID19943Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of PBZ and IDA at 1 uM1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID19942Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of PBZ and IDA at 0.1 uM1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID16761Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID196933Concentration that produces 50% of the maximal response to compound in rat thoracic aorta strips in the presence of PBZ and CIR1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
AID196941Concentration that produces 50% of the maximal response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips1994Journal of medicinal chemistry, Jun-10, Volume: 37, Issue:12
Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]